Michel Dahan, SVP, Chief Operating Officer at Akebia Therapeutics, Inc. (AKBA), sold 8,661 shares at $1.58 ($14K) on 2024-02-29, disclosed to the SEC on 2024-03-01.
Seasonal sale ($14k) by SVP, Chief Operating Officer — this insider has traded AKBA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AKBA | SELL | 2023-05-25 | $233K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $18K | — | Filing → |
| AKBA | SELL | 2023-03-01 | $8K | — | Filing → |